IDO-IN-9 |
| Katalog-Nr.GC33191 |
IDO-IN-9 ist ein Indolamin-2,3-Dioxygenase (IDO)-Inhibitor mit IC50-Werten von 0,011 μM (Kinase) und 0,0018 μM (Hela Cell), extrahiert aus dem Patent WO 2016041489 A1, Verbindung 6.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1888378-12-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
IDO-IN-9 is an indoleamine-2,3-dioxygenase (IDO) inhibitor with IC50s of 0.011 μM (Kinase) and 0.0018 μM (Hela Cell), extracted from patent WO 2016041489 A1, compound 6.
[1]. Wang, Zhaoyin et al. Inhibiteur de l'indoleamine-2,3-dioxygénase et son procédé de preparation. WO 2016041489 A1.
Average Rating: 5 (Based on Reviews and 22 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *